Enhancement of natural killer cell activity in mice by treatment with a thymic factor
- PMID: 6563944
- PMCID: PMC11039141
- DOI: 10.1007/BF00205497
Enhancement of natural killer cell activity in mice by treatment with a thymic factor
Abstract
The administration of a thymic factor, thymostimulin (TP-1), to mice resulted in considerable augmentation of natural killer (NK) cell activity as measured in a short-term assay against 51Cr-labeled YAC-1 target cells. Conditions suitable for detection of the thymostimulin-induced boosting of NK included multiple daily exposures to TP-1 (50 micrograms/kg), and peak levels of reactivity were observed at 2-4 days after discontinuation of treatment. A strict age-dependency of the effect was also observed, with optimal augmentation of NK-cell activity when TP-1 was administered to mice at 4-6 weeks of age. The effect was not limited to TP-1 treatment but was also observed on administration of another thymic factor (thymosin alpha 1). The activated cells responsible for the increased natural cell-mediated cytotoxicity appeared to be typical murine NK cells, judging by both functional and antigenic criteria.
Similar articles
-
Modulation of natural killer activity by thymosin alpha 1 and interferon.Cancer Immunol Immunother. 1985;20(3):189-92. doi: 10.1007/BF00205574. Cancer Immunol Immunother. 1985. PMID: 3851698 Free PMC article.
-
Combined effects of cyclophosphamide and thymostimulin treatment on the in vitro natural killer and candidacidal activity of murine spleen cells.Int J Tissue React. 1984;6(6):485-92. Int J Tissue React. 1984. PMID: 6530352
-
Thymostimulin effects on lymphoid organs in Ames dwarf mice.Acta Endocrinol (Copenh). 1993 Jan;128(1):74-80. doi: 10.1530/acta.0.1280074. Acta Endocrinol (Copenh). 1993. PMID: 8447198
-
Do natural killer cells engage in regulated reactions against self to ensure homeostasis?Immunol Rev. 1979;44:13-41. doi: 10.1111/j.1600-065x.1979.tb00266.x. Immunol Rev. 1979. PMID: 367948 Review.
-
Enhanced immune response and antitumor immunity with combinations of biological response modifiers.Bull N Y Acad Med. 1989 Jan;65(1):111-9. Bull N Y Acad Med. 1989. PMID: 2481523 Free PMC article. Review.
Cited by
-
Modulation of NK activity by thymic hormones: in vitro effects of thymostimulin.Med Oncol Tumor Pharmacother. 1989;6(1):45-52. doi: 10.1007/BF02985222. Med Oncol Tumor Pharmacother. 1989. PMID: 2725094
-
Thymic hormones--a clinical update.Springer Semin Immunopathol. 1986;9(1):1-18. doi: 10.1007/BF00201901. Springer Semin Immunopathol. 1986. PMID: 3014672 Review. No abstract available.
-
Thymosin-alpha1 modulates dendritic cell differentiation and functional maturation from human peripheral blood CD14+ monocytes.Immunol Lett. 2007 Jun 15;110(2):110-20. doi: 10.1016/j.imlet.2007.04.007. Epub 2007 May 15. Immunol Lett. 2007. PMID: 17532057 Free PMC article.
References
-
- Bach JF. Thymic hormones. J Immunopharmacol. 1979;1:277. - PubMed
-
- Bergesi G, Falchetti R. Caratterizzazione chimica e attività biologica di un nuovo estratto timico. Folia Allergol Immunol Clin. 1977;24:204–209.
-
- Chirigos MA. In vitro and in vivo studies with thymosin. In: Chirigos MA, editor. Immune modulation and control of neoplasia by adjuvant therapy. New York: Raven Press; 1978. pp. 305–315.
-
- Cikes M, Friberg S, Jr, Klein G. Progressive loss of H-2 antigen with concomitant increase of cell surface antigen(s) determined by Moloney leukemia virus in cultured murine lymphomas. J Natl Cancer Inst. 1973;50:347–362. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources